ArticleBioinformation2025
Correlation of serum adiponectin with thyroid profile among metabolic syndrome patients with and without hypothyroidism.
Article in Bioinformation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The Metabolic Syndrome is becoming a more significant global public health condition, and look for reliable, sensitive biomarkers that may be used as diagnostic tools to identify metabolic syndrome. Therefore, it is of interest to correlate the serum adiponectin with thyroid profile in metabolic syndrome patients with and without hypothyroidism. This is a cross-sectional study that included total 120 metabolic syndromes with and without hypothyroidism and 30 healthy controls. The analysis of biochemical and experimental parameters was done. The serum adiponectin was significant and drastically decreased levels was observed in metabolic syndrome patients with and without hypothyroidism and healthy controls (P = 0.001**). It was observed that serum adiponectin was negatively correlated with blood sugars, lipid profile, MDA, TSH and positively correlated with FRAP (P = 0.001**). Thus, we show significantly decreased levels of serum adiponectin among metabolic syndrome patients with and without hypothyroidism might be useful for identify complications like type 2 diabetes mellitus and cardiovascular diseases.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.